AM21-36: Oral Abstract Session -- Immunohematology and Rare Donors

Learning Objectives:

• Describe the antibody response differences seen in the abstract presented between phenotypic and genotypic matching for transfusion in patients with Sickle Cell Disease
• Discuss the applications for using the Surface Plasmon Resonance system for IgA detection
• Describe increased awareness of the critical importance of identifying and maintaining rare donors and knowledge of exquisitely rare types
• Recognize the importance of using the immunohematologic test methods appropriate to the investigation of an antibody to a high prevalence antigen to resolve the antibody specificity

Moderator(s):

• Ms. Sandra J. Nance, MS, MASCP, MT(ASCP)SBB, American Rare Donor Program
• Meta Morrison, New York Presbyterian Hospital

Speaker(s):

• Dr. Margaret A. Keller, PhD, Director, National Molecular Laboratory, American Red Cross Biomedical Services
• Danny Brouard, Héma-Québec
• Prof. Lilian Castilho, PhD, Hemocentro Unicamp
• Christine Lomas-Francis, MSc, FIBMS, New York Blood Center

Disclosures

• Sandra Nance, MS, MASCP, MT(ASCP)SBB:

  Nothing to Disclose

• Margaret Keller, PhD:

  Nothing to Disclose

• Meta Morrison:

  Nothing to Disclose